Deuterated phenanthrene
Term · Oncology and biomedicine · MLC-T-ONC-013003
A noncarcinogenic and structural analogue of polycyclic aromatic hydrocarbon (PAH), phenanthrene labeled with deuterium ([D10]Phe) with potential use in assessing an individual’s capacity for PAH metabolism by the diol epoxide pathway. Upon oral or inhalation administration, [D10]Phe is metabolized into the tetraol end product ([D10]PheT) via the diol epoxide pathway, and can be quantified in urine. [D10]PheT can be used as a biomarker to assess PAHs metabolic activation and may therefore determine an individual’s susceptibility to carcinogenicity upon PAH exposure.
| Identifier | MLC-T-ONC-013003 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | [D10]Phe |
| Synonyms | [D10] phenanthrene; phenanthrene-D10 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013003",
"term": "Deuterated phenanthrene",
"field": "Oncology and biomedicine",
"definition": "A noncarcinogenic and structural analogue of polycyclic aromatic hydrocarbon (PAH), phenanthrene labeled with deuterium ([D10]Phe) with potential use in assessing an individual’s capacity for PAH metabolism by the diol epoxide pathway. Upon oral or inhalation administration, [D10]Phe is metabolized into the tetraol end product ([D10]PheT) via the diol epoxide pathway, and can be quantified in urine. [D10]PheT can be used as a biomarker to assess PAHs metabolic activation and may therefore determine an individual’s susceptibility to carcinogenicity upon PAH exposure.",
"abbreviation": "[D10]Phe",
"synonyms": [
"[D10] phenanthrene",
"phenanthrene-D10"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/deuterated-phenanthrene/"
}
Record 5,881 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.